Fundacion Favaloro

Ciudad Autonoma Buenos Aires C1428ART

3 studies enrolling now · 7 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease, Connective Tissue Diseases, Dyslipidemia, Familial Primary Pulmonary Hypertension, Heart Failure, Hypertension, Hypertension, Pulmonary, Lung Diseases, PAH

Studies at this site

• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) — Stopped early